TARO LMT 25 (Lamotrigine 25 mg)

Pill imprint TARO LMT 25 has been identified as Lamotrigine 25 mg.

Lamotrigine is used in the treatment of bipolar disorder; seizure prevention; schizoaffective disorder; anxiety; cyclothymic disorder (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for TARO LMT 25

Lamotrigine 25 mg TARO LMT 25
Lamotrigine
Imprint:
TARO
LMT 25
Strength:
25 mg
Color:
White
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Triazine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Taro Pharmaceuticals U.S.A., Inc.
National Drug Code (NDC):
51672-4130
Inactive Ingredients:
croscarmellose sodium
crospovidone
lactose monohydrate
magnesium stearate
microcrystalline cellulose
povidone
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
33261-0647 Aidarex Pharmacuticals LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)